Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5
Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5
Alliance Global Partners以买入评级启动对丰泽生物技术的报道，宣布目标股价为5美元
Alliance Global Partners initiates coverage on Fortress Biotech (NASDAQ:FBIO) with a Buy rating and announces Price Target of $5.
Alliance Global Partners开始对丰泽生物科技（纳斯达克股票代码：FBIO）进行报道，评级为买入，并宣布目标股价为5美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。